KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$24.43
+0.33%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 106.7M | 95.1M | 59.8M | 27.8M | 7.6M |
| Cost of Revenue | 49.2M | 46.3M | 35.6M | 27.5M | 18.3M |
| Gross Profit | 57.5M | 48.9M | 24.2M | 362.0K | (10.7M) |
| Operating Expenses | |||||
| R&D Expense | 22.3M | 19.5M | 15.7M | 15.5M | 15.8M |
| SG&A Expense | 178.8M | 164.1M | 114.9M | 69.9M | 54.0M |
| General & Admin Expense | — | — | — | 29.3M | 19.1M |
| Selling & Marketing Expense | — | — | — | 40.7M | 34.9M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 201.0M | 183.6M | 130.6M | 85.4M | 69.8M |
| Cost and Expenses | 250.2M | 229.9M | 166.2M | 112.9M | 88.1M |
| Operating Income (EBIT) | (143.5M) | (134.7M) | (106.4M) | (85.1M) | (80.4M) |
| Non-Operating | |||||
| Interest Income | (392.0K) | 8.4M | 3.2M | — | — |
| Interest Expense | 7.6M | 7.5M | 7.7M | 6.2M | 5.6M |
| Net Interest Income | (3.7M) | 804.0K | (4.5M) | (6.2M) | (5.6M) |
| Other Non-Op Income/Expense | (6.0M) | 3.4M | (7.3M) | (9.0M) | (3.8M) |
| Non-Operating Income (excl Interest) | (3.4M) | 10.9M | (433.0K) | 2.8M | (1.8M) |
| EBT (Pre-Tax Income) | (149.6M) | (131.3M) | (113.7M) | (94.1M) | (84.2M) |
| Income Tax Expense | 311.0K | 294.0K | 135.0K | 24.0K | 15.0K |
| Bottom Line | |||||
| Net Income | (149.9M) | (131.6M) | (113.8M) | (94.1M) | (84.2M) |
| Earnings from Cont. Ops | (149.9M) | (131.6M) | (113.8M) | (94.1M) | (84.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (149.9M) | (131.6M) | (126.1M) | (100.8M) | (86.7M) |
| Per Share | |||||
| Basic EPS | ($2.67) | ($2.43) | ($5.13) | ($2.04) | ($1.75) |
| Diluted EPS | ($2.67) | ($2.43) | ($5.13) | ($2.04) | ($1.75) |
| Revenue Per Share | $1.82 | $1.63 | $1.21 | $0.56 | $0.15 |
| Shares | |||||
| Basic Shares Outstanding | 58.6M | 58.4M | 49.5M | 49.5M | 49.5M |
| Diluted Shares Outstanding | 58.6M | 58.4M | 49.5M | 49.5M | 49.5M |
| Profitability Metrics | |||||
| EBITDA | (143.9M) | (150.0M) | (98.0M) | (76.3M) | (73.7M) |
| D&A | (3.8M) | (4.4M) | 8.0M | 11.6M | 4.9M |
| EBIT | (140.1M) | (145.6M) | (105.9M) | (87.9M) | (78.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026